/ Most Recent /
Is Your Clinical Approach to SIBO Treatment Leading to Recurrence? (Podcast)
Why is SIBO (small intestinal bowel overgrowth) challenging to treat? Might the issue lie in hasty diagnoses and repetitive treatments without deeply exploring the root ...
Attention Issues in Children Linked to Common OTC Pain Reliever
Acetaminophen, sold over-the-counter as Tylenol and other brand names, is generally regarded as a safe and effective pain reliever when ...
New Research Uncovers Additional Reasons to Eat Kimchi
Kimchi, a traditional Korean dish made by salting and fermenting vegetables with various flavorings and seasonings, is well known as ...
The Ever-Evolving Microbiome—Ages and Stages
Research highlights specific patterns and transition points at various ages and stages of life, as well as significant impacts those changes have on long-term wellness—so ...
Surprising Benefits of Navy Beans
Beans, beans, good for the…gut? They are. At least according to new research from the University of Texas MD Anderson ...
Using Ayurvedic Herbs to Treat Stress
The ancient Indian healing system known as Ayurveda has been used for thousands of years to treat a wide variety ...
GlyNAC Research Review and Clinical Considerations
Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging ...
Demystifying Senescent Cells: Taking An Abstract Concept and Making It Real In Practice
Senescent cells, often referred to as zombie cells, are a fascinating aspect of cellular biology that plays a crucial role ...
The New Wave of Weight Loss
Blending pharmaceuticals, nutraceuticals and integrative approaches for safe, sustainable weight loss that works. Of all the challenges encountered by practitioners, ...
/ Top Articles /
Sorry, we couldn't find any posts. Please try a different search.
/ Weight Loss /
Stopping GLP-1 Receptor Agonists… Why and How to Plan an “Exit Strategy” for Your Patients
In recent years, the pharmaceutical landscape has seen the emergence of glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) such as semaglutide and tirzepatide, offering promising outcomes in weight reduction for those struggling with obesity. Landmark trials demonstrated significant weight loss in obese individuals. ...
Acknowledging Gender Differences in Obesity Research
With the celebration of International Women’s Day on March 8th, it’s timely to review the differences in women’s health research and how that specifically affects investigations into treatments for overweight and obesity. Obesity and overweight—gender similarities and differences By 2022, 8 billion ...
Researchers Link Abdominal Fat to Brain Health in Men
According to the World Health Organization, some 55 million people globally suffer from Alzheimer’s disease or dementia. With 10 million new cases diagnosed annually, dementia has become the seventh leading cause of death worldwide, and those numbers are only likely to grow ...
Amarasate, An Extract of Bitter Hop Flowers Shown Effective For Weight Loss: The Science And Mode Of Action
With the massive interest in the use of glucagon-like peptide-1 (GLP-1) receptor agonists for the management of both Type 2 diabetes and obesity/overweight, it is timely to review the mode of action of these medications and that of an alternative GLP-1-stimulating nutraceutical. ...
Multiple Human Studies Show Significant Weight-Loss Benefits for Amarasate, A Proprietary Extract of Bitter Hops
A trio of studies performed in the past 5 years shows that a proprietary hops extract called Amarasate can help curb hunger and food cravings.
Supporting Integrative Practitioners Since 2013
